MacroGenics Inc. Stock
MacroGenics Inc. Stock
There is an upward development for MacroGenics Inc. compared to yesterday, with an increase of €0.18 (1.130%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on MacroGenics Inc..
With a target price of 20 € there is a positive potential of 27.39% for MacroGenics Inc. compared to the current price of 15.7 €.
Our community identified positive and negative aspects for MacroGenics Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the MacroGenics Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of MacroGenics Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MacroGenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MacroGenics Inc. | 1.130% | -9.038% | 9.790% | 151.200% | 74.444% | -40.799% | - |
| Ardelyx Inc. | -1.020% | -12.086% | -15.475% | 35.391% | 4.706% | -16.524% | - |
| Salarius Pharmaceuticals Inc. | 1.850% | 10.553% | -19.266% | -71.613% | -20.721% | -98.176% | -99.994% |
| Evolus Inc | -1.830% | -7.627% | -15.504% | 39.744% | 16.578% | 15.344% | - |
Comments
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Show more
Ratings data for MGNX provided by MarketBeat
News
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q4 2023 Earnings CallMar 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET
Operator
Source Fool.com